Expert Opinion on Drug Safety

Safety issues associated with the use of angiotensin-converting enzyme inhibitors
pp. 739-740(2)
Author: Ehlers, Mario R

Topiramate-induced psychosis: report of two cases
pp. 741-742(2)
Authors: Teive, Hélio AG; Arruda, Walter Oleschko; Munhoz, Renato P; Werneck, Lineu C

Osteonecrosis of the jaw: what do bisphosphonates do?
pp. 743-745(3)
Author: Aspenberg, Per

Safety and risk communication to patients
pp. 747-750(4)
Authors: Thürmann, Petra A

The safety of anidulafungin
pp. 751-758(8)
Authors: Vazquez, José A

Drug-induced parkinsonism
pp. 759-771(13)
Authors: Mena, Maria A; de Yébenes, Justo G

The safety of dental amalgam in children
pp. 773-781(9)
Authors: Martin, Michael D; Woods, James S

Nasal decongestants in the treatment of chronic nasal obstruction: efficacy and safety of use
pp. 783-790(8)
Authors: Passàli, Desiderio; Salerni, Lorenzo; Passàli, Giulio Cesare; Passàli, Francesco Maria; Bellussi, Luisa

Anthracycline cardiotoxicity
pp. 791-809(19)
Authors: Jones, Robin L; Swanton, Charles; Ewer, Michael S

Risk of atrial fibrillation with high-dose corticosteroids
pp. 811-814(4)
Authors: Chiappini, Bruno; El Khoury, Gebrine

The safety and efficacy of aspirin and clopidogrel as a combination treatment in patients with coronary heart disease
pp. 815-826(12)
Authors: Cooke, Glen E; Goldschmidt-Clermont, Pascal J

Comparative safety of newer oral antidiabetic drugs
pp. 827-834(8)
Author: Krentz, Andrew J

Clinical safety of the selective PKC-β inhibitor, ruboxistaurin
pp. 835-845(11)
Authors: McGill, Janet B; King, George L; Berg, Paul H; Price, Karen L; Kles, Keri A; Bastyr, Edward J; Hyslop, David L

Safety and efficacy of use of demineralised bone matrix in orthopaedic and trauma surgery
pp. 847-866(20)
Authors: Dinopoulos, Haralampos TH; Giannoudis, Peter V

Corrigendum
pp. 875-875(1)